Literature DB >> 15809815

Overview of acutely decompensated congestive heart failure (ADHF): a report from the ADHERE registry.

Gregg C Fonarow1, Eliot Corday.   

Abstract

Acute decompensated heart failure (ADHF) has emerged as a major public health problem, and HF has become the leading cause of hospitalization in persons over 65 years of age. It is estimated that there are 6.5 million hospital days attributed to ADHF each year. Patients hospitalized with ADHF face a substantial risk of readmission, as high as 50% by 6 months after discharge. Despite the large number of patients hospitalized and this substantial risk, data on these patients have been limited and there has been little effort to improve the quality of care for patients hospitalized with ADHF. The Acute Decompensated Heart Failure National Registry (ADHERE) was designed to bridge this gap in knowledge and care by prospectively studying the characteristics, management, and outcomes of a broad spectrum of patients hospitalized with ADHF. Participating community and university hospitals identified patients with a primary or secondary discharge diagnosis of HF and collected medical history, management, treatments, and health outcomes via secure Web browser technology. As of October 2004, more than 160,000 patients from 281 hospitals have been enrolled. These patients differ substantially from those typically enrolled in randomized clinical trials. Initial data from the ADHERE registry have provided important insights into the clinical characteristics, patterns of care, and outcomes of patients with ADHF. ADHERE has documented significant delays in diagnosis and initiation of ADHF therapies as well as a substantial under-use of evidenced-based, guideline-recommended chronic HF therapies at hospital discharge. As such, there are substantial opportunities to improve the quality of care for ADHF patients in the nation's hospitals.

Entities:  

Mesh:

Year:  2004        PMID: 15809815     DOI: 10.1007/s10741-005-6127-6

Source DB:  PubMed          Journal:  Heart Fail Rev        ISSN: 1382-4147            Impact factor:   4.214


  6 in total

1.  Improved treatment of coronary heart disease by implementation of a Cardiac Hospitalization Atherosclerosis Management Program (CHAMP).

Authors:  G C Fonarow; A Gawlinski; S Moughrabi; J H Tillisch
Journal:  Am J Cardiol       Date:  2001-04-01       Impact factor: 2.778

2.  Rationale, design, and methods for a Coreg (carvedilol) Heart Failure Registry (COHERE). COHERE Participant Physicians.

Authors:  J A Franciosa; W T Abraham; M Fowler; E M Gilbert; B Greenberg; B M Massie; T Chen; M A Lukas; J J Nelson
Journal:  J Card Fail       Date:  2000-09       Impact factor: 5.712

3.  Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial.

Authors:  Michael S Cuffe; Robert M Califf; Kirkwood F Adams; Raymond Benza; Robert Bourge; Wilson S Colucci; Barry M Massie; Christopher M O'Connor; Ileana Pina; Rebecca Quigg; Marc A Silver; Mihai Gheorghiade
Journal:  JAMA       Date:  2002-03-27       Impact factor: 56.272

4.  ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1995 Guidelines for the Evaluation and Management of Heart Failure).

Authors:  S A Hunt; D W Baker; M H Chin; M P Cinquegrani; A M Feldman; G S Francis; T G Ganiats; S Goldstein; G Gregoratos; M L Jessup; R J Noble; M Packer; M A Silver; L W Stevenson; R J Gibbons; E M Antman; J S Alpert; D P Faxon; V Fuster; A K Jacobs; L F Hiratzka; R O Russell; S C Smith
Journal:  J Am Coll Cardiol       Date:  2001-12       Impact factor: 24.094

5.  Readmission after hospitalization for congestive heart failure among Medicare beneficiaries.

Authors:  H M Krumholz; E M Parent; N Tu; V Vaccarino; Y Wang; M J Radford; J Hennen
Journal:  Arch Intern Med       Date:  1997-01-13

Review 6.  The role of in-hospital initiation of cardioprotective therapies to improve treatment rates and clinical outcomes.

Authors:  Gregg C Fonarow
Journal:  Rev Cardiovasc Med       Date:  2002       Impact factor: 2.930

  6 in total
  33 in total

1.  Management of Cardio-Renal Syndrome and Diuretic Resistance.

Authors:  Frederik H Verbrugge; Wilfried Mullens; W H Wilson Tang
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-02

2.  Length of hospital stay and its impact on subsequent early readmission in patients with acute heart failure: a report from the WET-HF Registry.

Authors:  Hidenori Moriyama; Takashi Kohno; Shun Kohsaka; Yasuyuki Shiraishi; Ryoma Fukuoka; Yuji Nagatomo; Ayumi Goda; Atsushi Mizuno; Keiichi Fukuda; Tsutomu Yoshikawa
Journal:  Heart Vessels       Date:  2019-05-27       Impact factor: 2.037

3.  Optimal use of diuretics in patients with heart failure.

Authors:  Jigar Patel; Michael Smith; J Thomas Heywood
Journal:  Curr Treat Options Cardiovasc Med       Date:  2007-08

Review 4.  New insights into combinational drug therapy to manage congestion in heart failure.

Authors:  Frederik Hendrik Verbrugge; Lars Grieten; Wilfried Mullens
Journal:  Curr Heart Fail Rep       Date:  2014-03

Review 5.  Management of the cardiorenal syndrome in decompensated heart failure.

Authors:  Frederik Hendrik Verbrugge; Lars Grieten; Wilfried Mullens
Journal:  Cardiorenal Med       Date:  2014-12       Impact factor: 2.041

6.  Mechanistic Insights into Loop Diuretic Responsiveness in Heart Failure.

Authors:  David H Ellison
Journal:  Clin J Am Soc Nephrol       Date:  2019-04-22       Impact factor: 8.237

Review 7.  The 2010 Canadian Cardiovascular Society guidelines for the diagnosis and management of heart failure update: Heart failure in ethnic minority populations, heart failure and pregnancy, disease management, and quality improvement/assurance programs.

Authors:  Jonathan G Howlett; Robert S McKelvie; Jeannine Costigan; Anique Ducharme; Estrellita Estrella-Holder; Justin A Ezekowitz; Nadia Giannetti; Haissam Haddad; George A Heckman; Anthony M Herd; Debra Isaac; Simon Kouz; Kori Leblanc; Peter Liu; Elizabeth Mann; Gordon W Moe; Eileen O'Meara; Miroslav Rajda; Samuel Siu; Paul Stolee; Elizabeth Swiggum; Shelley Zeiroth
Journal:  Can J Cardiol       Date:  2010-04       Impact factor: 5.223

8.  Rapid and Highly Accurate Prediction of Poor Loop Diuretic Natriuretic Response in Patients With Heart Failure.

Authors:  Jeffrey M Testani; Jennifer S Hanberg; Susan Cheng; Veena Rao; Chukwuma Onyebeke; Olga Laur; Alexander Kula; Michael Chen; F Perry Wilson; Andrew Darlington; Lavanya Bellumkonda; Daniel Jacoby; W H Wilson Tang; Chirag R Parikh
Journal:  Circ Heart Fail       Date:  2016-01       Impact factor: 8.790

9.  The worst symptom as defined by patients during heart failure hospitalization: implications for response to therapy.

Authors:  Mahoto Kato; Lynne W Stevenson; Maryse Palardy; Patricia M Campbell; Christopher W May; Neal K Lakdawala; Garrick Stewart; Anju Nohria; Joseph G Rogers; J Thomas Heywood; Mihai Gheorghiade; Eldrin F Lewis; Xiaojuan Mi; Soko Setoguchi
Journal:  J Card Fail       Date:  2012-05-30       Impact factor: 5.712

10.  Epidemiology of decompensated heart failure in a single community in the northeastern United States.

Authors:  Robert J Goldberg; Chad Darling; Bernard Joseph; Jane Saczynski; Marcello Chinali; Darleen Lessard; Steven Pezzella; Frederick A Spencer
Journal:  Am J Cardiol       Date:  2009-06-06       Impact factor: 2.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.